With dozens of approvals expected in the coming years, the cell and gene therapy space has turned into a goldmine for contract manufacturers. But COVID-19 vaccines are also a potentially lucrative ...
To continue to be profitable in the future, biomanufacturers should take some tips from the food business. That was one of the take home messages at the recent “Biologicals Manufacturing Summit,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results